The weight loss drugs, by mimicking gut hormones, effectively reduce appetite and promote weight loss, which can in turn ...

The Medicines and Healthcare products Regulatory Agency reports dozens of cases among women injecting weight loss drugs.

The MHRA issued the warning amid concerns that the medications may not be used safely. There have been previous reports ...

U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of ...

Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...

Ozempic, which was introduced into the UK in January 2019, having previously been approved in the US in 2017, is an ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance for thousands of women who use the ...

The UK's drug safety watchdog is to open a new "digital hub" in West Yorkshire. The site, to be located in Leeds city centre, ...

Demand for weight-loss drugs, including GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, has surged in the United States. In May 2024, a KFF Health Tracking Poll found that approximately 6 ...

As women report having "Ozempic babies", the warning comes because there is not enough safety data to know whether taking the ...

Leeds plays a crucial role in driving improved patient care through hi-tech advancements, according to Health Secretary Wes ...

As difficult-to-treat infections continue to rise, phage therapies are becoming important complements to existing treatments.